Health Care: Drugs

Apricus Biosciences Inc (APRI: NASDAQ)

$2.14 -0.08 | -3.6%
03/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 5.76M 4.84M 9.26M 2.51M
Cost of Sales 3.60M 622.00K 585.00K 2.30M
Gross Operating Profit 2.16M 4.22M 8.67M 207.00K
Selling, General, and Administrative Expenses 8.43M 10.52M 11.42M 13.55M
Research & Development 6.83M 14.65M 21.29M 5.12M
Operating Income before D & A (EBITDA) -13.10M -20.95M -24.03M -18.47M
Depreciation & Amortization 289.00K 300.00K 333.00K 327.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 6.98M 3.12M 2.23M 3.65M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -6.41M -18.13M -22.14M -15.14M
Interest Expense 1.02M 895.00K 339.00K 727.00K
Pre-Tax Income -7.43M -19.02M -22.48M -15.87M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -7.43M -19.02M -22.48M -15.87M
Net Income From Discontinued Operations 0.00 0.00 691.00K -1.07M
Net Income From Total Operations -7.43M -19.02M -21.79M -16.94M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -7.43M -19.02M -21.79M -16.94M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-7.43M -19.02M -22.48M -15.87M
Preferred Dividends
Net Income Available To Common -7.43M -19.02M -22.48M -15.87M
Basic EPS from Continuing Ops. -1.14 -3.83 -5.70 -4.60
Basic EPS from Discontinued Ops. 0.00 0.00 0.20 -0.30
Basic EPS from Total Operations -1.14 -3.83 -5.50 -4.90
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.14 -3.83 -5.50 -4.90
Basic Normalized Net Income/Share -1.14 -3.83 -5.70 -4.60
EPS fr Continuing Ops. -1.14 -3.83 -5.70 -4.60
EPS fr Discontinued Ops 0.00 0.00 0.20 -0.30
EPS fr Total Ops. -1.14 -3.83 -5.50 -4.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.14 -3.83 -5.50 -4.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.14 -3.83 -5.70 -4.60
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with APRI

Latest APRI Headlines from TheStreet

More Financial News for APRI

Press Releases for APRI

See All Press Releases

Partner Headlines for APRI

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter